Xin Zhao

Title: Innovations in Microbial Research by Xin Zhao

Introduction

Xin Zhao is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of microbial research, particularly in the area of inflammatory colon cancer. His work focuses on the application of specific microbial strains to improve health outcomes.

Latest Patents

Xin Zhao holds a patent for "Lacticaseibacillus rhamnosus AFY01 and application of product prepared from lacticaseibacillus rhamnosus AFY01 in inflammatory colon cancer." This patent, identified by the preservation number CGMCC No. 27362, details how AFY01 can effectively alleviate weight loss, intestinal inflammation, and edema induced colon shortening in mice with colon cancer. The research demonstrates that AFY01 can reduce colon coefficient, visceral index, and the incidence of intestinal tumors in mice. Additionally, it promotes apoptosis of intestinal tumor cells, thereby slowing down the development of colon cancer. This innovation expands bacterial resources and provides technical support for the prevention and treatment of colorectal cancer.

Career Highlights

Xin Zhao is affiliated with Chongqing University of Education, where he continues to advance his research in microbial applications. His work has garnered attention for its potential impact on cancer treatment and prevention.

Collaborations

Xin Zhao collaborates with notable colleagues, including Fang Tan and Xin Ma, who contribute to his research efforts. Their combined expertise enhances the quality and scope of their work in microbial research.

Conclusion

Xin Zhao's innovative research in microbial applications for inflammatory colon cancer represents a significant advancement in the field. His contributions not only highlight the potential of microbial strains in medical applications but also pave the way for future research in cancer prevention and treatment.